Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exp...

Full description

Bibliographic Details
Main Authors: Jolanda Sabatino, Giovanni Di Salvo, Giuseppe Calcaterra, Pier Paolo Bassareo, Lilia Oreto, Ilaria Cazzoli, Maria Pia Calabrò, Paolo Guccione, Michael A. Gatzoulis
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:International Journal of Cardiology Congenital Heart Disease
Subjects:
ACHD
COVID-19
Vaccine
Risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666668521001105
Description
Summary:Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.
ISSN:2666-6685

Similar Items